Cytocares - Crunchbase Company Profile & Funding

Q: Where is Cytocares's headquarters?

Cytocares is located in Shanghai, Shanghai, China.

Q: Who invested in Cytocares?

Cytocares has 6 investors including Shanghai Tellgen Life Science And Prosperico Ventures.

Q: When was the last funding round for Cytocares?

Cytocares closed its last funding round on obfuscated from a Series A round.

Q: How much funding has Cytocares raised to date?

Cytocares has raised obfuscated.

Overview

Cytocares

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Cytocares

CB Rank

65257

Cytocares offers innovative drug design for antibody novel medication creation and development in the realm of tumor immunity.

Founded

obfuscation

Private

Series A

Shanghai, Shanghai, China

1-10

www.cytocares.com

Biotechnology

Medical

Product Research

Funding Rounds

Series A

OBF

obfuscation

Series A

OBF

obfuscation

Details

Legal Name

Huihe Biotechnology (Shanghai) Co., Ltd.

Also Known As

Huihe Biotech, Huihe Biotechnology, Shanghai Huihe Biologics, Huihe biological

Operating Status

Active

Company Type

For Profit

About the Company

Cytocares offers innovative drug design for antibody novel medication creation and development in the realm of tumor immunity.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

TriTE™ Platform

A trispecific T-cell engager platform that activates T cells by co-engaging TCR/CD3 and the co-stimulatory receptor CD28 to enhance immune response against tumors.

CCNK™ Platform

A platform for developing antibodies that modulate natural killer (NK) cell activity to promote tumor cell killing.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Cytocares	1	obfuscated obfuscation	Shanghai Tellgen Life Science	Series A
obfuscated obfuscation	Series A - Cytocares	1	obfuscated obfuscation	Shanghai Tellgen Life Science	Series A
obfuscated obfuscation	Series A - Cytocares	1	obfuscated obfuscation	Shanghai Tellgen Life Science	Series A
obfuscated obfuscation	Series A - Cytocares	1	obfuscated obfuscation	Shanghai Tellgen Life Science	Series A
obfuscated obfuscation	Series A - Cytocares	1	obfuscated obfuscation	Shanghai Tellgen Life Science	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Cytocares	1	obfuscated obfuscation	Shanghai Tellgen Life Science	Series A
obfuscated obfuscation	Series A - Cytocares	1	obfuscated obfuscation	Shanghai Tellgen Life Science	Series A
obfuscated obfuscation	Series A - Cytocares	1	obfuscated obfuscation	Shanghai Tellgen Life Science	Series A
obfuscated obfuscation	Series A - Cytocares	1	obfuscated obfuscation	Shanghai Tellgen Life Science	Series A
obfuscated obfuscation	Series A - Cytocares	1	obfuscated obfuscation	Shanghai Tellgen Life Science	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Shanghai Tellgen Life Science	Yes	Series A - Cytocares	—
Shanghai Tellgen Life Science	Yes	Series A - Cytocares	—
Shanghai Tellgen Life Science	Yes	Series A - Cytocares	—
Shanghai Tellgen Life Science	Yes	Series A - Cytocares	—
Shanghai Tellgen Life Science	Yes	Series A - Cytocares	—